Patient-Customized Oligonucleotide Therapy for a Rare Genetic DiseaseJin‐Kuk Kim, Timothy W. Yu, Aubrie Soucy et al.|New England Journal of Medicine|2019Cited by 808
Activation of -Glucocerebrosidase Reduces Pathological -Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain NeuronsJoseph R. Mazzulli, Dimitri Krainc|Journal of Neuroscience|2016Cited by 275
Increased Lysosomal Exocytosis Induced by Lysosomal Ca<sup>2+</sup> Channel Agonists Protects Human Dopaminergic Neurons from α-Synuclein ToxicityTaiji Tsunemi, Dimitri Krainc, Tamara Perez‐Rosello et al.|Journal of Neuroscience|2019Cited by 163
Distinct Region-Specific α-Synuclein Oligomers in A53T Transgenic Mice: Implications for NeurodegenerationElpida Tsika, Joseph R. Mazzulli|Journal of Neuroscience|2010Cited by 99
Nuclear aggregates of NONO/SFPQ and A-to-I-edited RNA in Parkinson’s disease and dementia with Lewy bodiesNandkishore R. Belur, Joseph R. Mazzulli|Neuron|2024Cited by 23